Tatyana Pechaeva, Managing Director of the Lekhim Group, one of Ukraine’s top ten domestic pharmaceutical companies, shares the main principles of her strategy which have enabled Lekhim to display high growth rates over recent years despite the country’s unstable economy.
The Lekhim group of companies was one of the pioneers of the Ukrainian pharmaceutical sector, becoming the first company in Ukraine to launch suppository production in 1995 – among many other achievements. Where does the company stand in 2017?
"Production capacity, state-of-the-art laboratories, a highly skilled workforce, final consumer orientation, and permanent development are the constituents which have allowed Lekhim to provide the domestic market with vital medicines"
